BEVERLY HILLS, Calif., April 5, 2012 /PRNewswire/ -- According to recent figures released by the Associated

SACRAMENTO, Calif., March 21, 2012 /PRNewswire/ -- The McClatchy Company (NYSE-MNI) announced today that Gary B.

The makers of three previously rejected weight loss drugs have resubmitted their products to the Food and Drug Administration (FDA) for approval, with each hoping to become the first new prescription anti-obesity drug to be approved in the U.S. in 13 years.

ST. PETERSBURG, Fla., Feb.

NEW YORK, Feb.